›› 2019, Vol. 46 ›› Issue (7): 2144-2150.doi: 10.16431/j.cnki.1671-7236.2019.07.032

• Basic Veterinary Medicine • Previous Articles     Next Articles

Yeast Expression of Recombinant Canine Alpha Interferon 6 and Evaluation of Their Antiviral Activities

SONG Tianqi1,2, HOU Shaohua1, GUO Xiaoyu1, XIN Ting1, JIANG Yitong1, YUAN Weifeng1, ZHU Hongfei1, JIA Hong1   

  1. 1. Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China;
    2. Beijing Tongzhou District Animal Health Supervision, Beijing 101100, China
  • Received:2018-11-25 Online:2019-07-20 Published:2019-07-22

Abstract:

The aim of the experiment was to construct the expression system of canine interferon alpha 6 (CaIFN-α6) in Pichia pastoris,optimize and screen the expression system in order to obtain recombinant canine interferon alpha 6 with high activity.According to the sequence of CaIFN-α6 gene and the codon preference of Pichia pastoris,the whole gene sequence of CaIFN-α6 was optimized and synthesized.The recombinant expression plasmid of pPICZαA-CaIFN-α6 was constructed using Xho Ⅰ and Not Ⅰ and linked to the vector pPICZαA.The recombinant expression plasmid was transformed into E.coli DH5α competent cells.The plasmid pPICZαA-CaIFN-α6 was extracted and linearized.The recombinant strain was prepared by electroporation into yeast competent cell X33.The recombinant CaIFN-α6 was purified by methanol induction,supernatant collection and ultrafiltration concentration.The concentration of purified CaIFN-α6 protein was 1.5 mg/mL by BCA.Western blotting analysis showed that CaIFN-α6 protein had good reactivity.SDS-PAGE showed that the purity of CaIFN-α6 protein was above 95%.The titer of CaIFN-α6 protein was 2.37×107 IU/mL by MDCK/VSV detection and the specific activity was 1.58×107 IU/mg.The results showed that CaIFN-α6 was successfully expressed in Pichia pastoris pPICZαA expression vector system with high biological activity,which provided a good support for the clinical prevention and treatment of canine viral disease in the later stage.

Key words: canine interferon alpha 6(CaIFN-α6); eukaryotic expression; purification; antiviral activity

CLC Number: